A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in postmenopausal women with osteoporosis. We assessed the effects of annual ...

Men with osteoporosis who received zoledronic acid experienced a ... only received the first infusion. A significantly lower proportion of men in the treatment group (1.6%) sustained at least ...

A single injection of zoledronic ... Osteoporosis Foundation-sponsored International Symposium on Osteoporosis, held in Washington, D.C. After two years, both zoledronic acid treatment regimens ...

June 1 -- The FDA has approved zoledronic acid (Reclast) to prevent postmenopausal osteoporosis for two years with a single injection. The drug is currently approved as a once-yearly infusion for ...

June 4, 2009 — The FDA this month has approved zoledronic acid infusion (Reclast ... acid previously was approved for the treatment of osteoporosis to reduce the incidence of hip, vertebral ...

That is why I am considering a treatment plan currently. — D.B. ANSWER: Osteoporosis is decreased ... of medicine called a bisphosphonate. Zoledronic acid (Reclast) is an injectable form of ...

I have osteoporosis and have had two bone scans ... is generally the first-line medication that is recommended. Zoledronic acid (Reclast) is in the same class, but is given by IV infusion, usually ...

The American College of Physicians’ new osteoporosis ... zoledronic acid (Reclast), and pamidronate (Aredia). Such medications are significantly less expensive than other pharmacologic ...

Zoledronic acid and denosumab demonstrated comparable fracture and mortality outcomes among patients with type 2 diabetes and osteoporosis ... valuable insights for treatment strategies in ...

Patients who were receiving treatment with oral ... end point in men with osteoporosis showed that over a 2-year period, a once-yearly infusion of zoledronic acid at a dose of 5 mg was associated ...

The researchers identified a cohort of women with osteoporosis aged 65 to 89 years who received their first annual infusion ... zoledronic acid, or 2 fewer events per 1000 person-years of ...